PCV18 COST OF ACHIEVING LDL REDUCTION AMONG PATIENTS TREATED WITH EZETIMIBE CO-ADMINISTRATION COMPARED TO STATIN MONOTHERAPY IN THE UK
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)74545-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)74545-9/fulltext
Title :
PCV18 COST OF ACHIEVING LDL REDUCTION AMONG PATIENTS TREATED WITH EZETIMIBE CO-ADMINISTRATION COMPARED TO STATIN MONOTHERAPY IN THE UK
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74545-9&doi=10.1016/S1098-3015(10)74545-9
First page :
Section Title :
Open access? :
No
Section Order :
471